Recessive ciliopathy mutations in primary endocardial fibroelastosis: a rare neonatal cardiomyopathy in a case of Alstrom syndrome

[1]  I. My,et al.  Genetic Cardiomyopathies: The Lesson Learned from hiPSCs , 2021, Journal of clinical medicine.

[2]  J. Sanchez-de-Toledo,et al.  Neonatal Non-compacted Cardiomyopathy: Predictors of Poor Outcome , 2019, Pediatric Cardiology.

[3]  S. Amselem,et al.  Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia. , 2019, American journal of human genetics.

[4]  D. Henderson,et al.  Cilia, mitochondria, and cardiac development. , 2019, The Journal of clinical investigation.

[5]  Kristin M. French,et al.  Fibroblast Primary Cilia Are Required for Cardiac Fibrosis. , 2019, Circulation.

[6]  W. Chung,et al.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association. , 2018, Circulation.

[7]  T. Hearn.  ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits , 2018, Journal of Molecular Medicine.

[8]  Maggie S. Matern,et al.  Genomic knockout of alms1 in zebrafish recapitulates Alström syndrome and provides insight into metabolic phenotypes , 2018, bioRxiv.

[9]  R. Sinke,et al.  Toward an effective exome-based genetic testing strategy in pediatric dilated cardiomyopathy , 2018, Genetics in Medicine.

[10]  M. Maleki,et al.  Next generation sequencing applications for cardiovascular disease , 2018, Annals of medicine.

[11]  X. Xiao,et al.  Wnt11 regulates cardiac chamber development and disease during perinatal maturation. , 2017, JCI insight.

[12]  Kathy O. Lui,et al.  Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium , 2017, Cell Research.

[13]  N. Klena,et al.  Cilia and Ciliopathies in Congenital Heart Disease. , 2017, Cold Spring Harbor perspectives in biology.

[14]  S. Nelson,et al.  A Path to Implement Precision Child Health Cardiovascular Medicine , 2017, Front. Cardiovasc. Med..

[15]  H. Guimarães,et al.  Neonatal dilated cardiomyopathy. , 2017, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[16]  J. Reiter,et al.  Cilia and Obesity. , 2017, Cold Spring Harbor perspectives in biology.

[17]  X. Xiao,et al.  Decoding the Long Noncoding RNA During Cardiac Maturation: A Roadmap for Functional Discovery , 2016, Circulation. Cardiovascular genetics.

[18]  N. Zaghloul,et al.  Whole organism transcriptome analysis of zebrafish models of Bardet-Biedl Syndrome and Alström Syndrome provides mechanistic insight into shared and divergent phenotypes , 2016, BMC Genomics.

[19]  Neil A. Miller,et al.  Alström Syndrome: Mutation Spectrum of ALMS1 , 2015, Human mutation.

[20]  Janan T. Eppig,et al.  Global genetic analysis in mice unveils central role for cilia in congenital heart disease , 2015, Nature.

[21]  P. D. del Nido,et al.  Endocardial fibroelastosis is caused by aberrant endothelial to mesenchymal transition. , 2015, Circulation research.

[22]  H. Peeters,et al.  Homozygous loss-of-function mutation in ALMS1 causes the lethal disorder mitogenic cardiomyopathy in two siblings. , 2014, European journal of medical genetics.

[23]  L. Fernandez,et al.  Mutations in Alström Protein Impair Terminal Differentiation of Cardiomyocytes , 2014, Nature Communications.

[24]  M. Fishbein,et al.  Primary endocardial fibroelastosis: an underappreciated cause of cardiomyopathy in children. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[25]  K. Safranow,et al.  Common genetic variants of the BMP4, BMPR1A, BMPR1B, and ACVR1 genes, left ventricular mass, and other parameters of the heart in newborns. , 2012, Genetic testing and molecular biomarkers.

[26]  W. Pu,et al.  Endocardial and Epicardial Epithelial to Mesenchymal Transitions in Heart Development and Disease , 2012, Circulation research.

[27]  David I. Wilson,et al.  Centriolar Association of ALMS1 and Likely Centrosomal Functions of the ALMS Motif–containing Proteins C10orf90 and KIAA1731 , 2010, Molecular biology of the cell.

[28]  W. Meschino,et al.  Mitogenic cardiomyopathy: a lethal neonatal familial dilated cardiomyopathy characterized by myocyte hyperplasia and proliferation. , 2010, Human pathology.

[29]  J. Naggert,et al.  Alström Syndrome , 2007, European Journal of Human Genetics.

[30]  P. Fernhoff,et al.  X‐linked fetal cardiomyopathy caused by a novel mutation in the TAZ gene , 2006, Prenatal diagnosis.

[31]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[32]  F. Ichida,et al.  Endocardial fibroelastosis in two siblings with the infantile type and the childhood type , 1986, European Journal of Pediatrics.

[33]  David I. Wilson,et al.  Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. , 2005, Diabetes.

[34]  David I. Wilson,et al.  Subcellular Localization of ALMS 1 Supports Involvement of Centrosome and Basal Body Dysfunction in the Pathogenesis of Obesity , Insulin Resistance , and Type 2 Diabetes , 2005 .

[35]  David I. Wilson,et al.  Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome , 2002, Nature Genetics.

[36]  W. V. So,et al.  Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome , 2002, Nature Genetics.

[37]  P. Lurie.  Endocardial fibroelastosis is not a disease. , 1988, The American journal of cardiology.

[38]  W. Roberts,et al.  Histologic and ultrastructural features of primary and secondary endocardial fibroelastosis. , 1977, Archives of pathology & laboratory medicine.

[39]  R. Harris,et al.  Heredity in primary endocardial fibroelastosis. , 1975, British heart journal.

[40]  J. Keith,et al.  The Diagnosis of Primary Endocardial Fibroelastosis , 1964, Circulation.

[41]  L. Nilsson,et al.  Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree. , 1959, Acta psychiatrica et neurologica Scandinavica. Supplementum.